CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Carvediloldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00964678
NCT00964678Phase 2Completed
CompareCT.gov

Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension

Virginia Commonwealth University·interventional·Posted Aug 25, 2009·Updated Jun 8, 2017

In Brief

A Phase 2 clinical trial evaluating Carvedilol for Pulmonary Arterial Hypertension. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether carvedilol treatment of patients with pulmonary arterial hypertension and associated right heart failure is safe and results in an improved function of the right heart.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Arterial Hypertension
CountriesUnited States
CollaboratorsGlaxoSmithKline

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 25, 2009
Enrollment StartJun 1, 2010
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 16.9 years ago

Interventions

Carvediloldrug

twice daily oral treatment in escalating dose